High adherence to prophylaxis regimens in haemophilia B patients receiving rIX‐FP: Evidence from clinical trials and real‐world practice

INTRODUCTION: Adherence to prophylaxis regimens is essential for bleed prevention in haemophilia but remains a challenge due to the need for frequent infusions. AIM: To evaluate patient adherence to prophylaxis regimens with a long‐acting recombinant factor IX (rIX‐FP; IDELVION(®)) in clinical studi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mancuso, Maria Elisa, Oldenburg, Johannes, Boggio, Lisa, Kenet, Gili, Chan, Anthony, Altisent, Carmen, Seifert, Wilfried, Santagostino, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496492/
https://www.ncbi.nlm.nih.gov/pubmed/32542961
http://dx.doi.org/10.1111/hae.14018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496492/
https://www.ncbi.nlm.nih.gov/pubmed/32542961
http://dx.doi.org/10.1111/hae.14018

Ejemplares similares